Handbook of Topical Drug Treatment in Dermatology

This book is the first authoritative volume dedicated to topical medication treatments in dermatology. This book provides an up-to-date synopsis of the clinical applications and uses of topical drugs in dermatological diseases. It provides to the reader at their fingertips - the recommended dermatologic uses for topical drugs. It correlates dermatologic conditions with topical drug treatments listed alphabetically. In addition, this volume discusses the clinical implications, special patient populations, drug pharmacokinetics, adverse effects and precautions, and will make comparisons to other therapeutic alternatives to treat a dermatologic condition, as appropriate.

Handbook of Topical Drug Treatment in Dermatology is an essential resource for physicians, pharmacists, fellows, residents in dermatology and general medical practice, as well as students in medicine, pharmacy and other health care professions. It serves as a companion handbook to the Handbook of Systemic Drug Treatment in Dermatology, currently in its 3rd edition.

The first authoritative volume dedicated to topical medication treatment in dermatology Offers an up-to-date synopsis of the clinical applications and uses of topical drugs Provides recommended dermatologic uses for topical drug treatments as well as other therapeutic alternatives

Autorentext

Dr. Rebecca M. Law has expertise in dermatology, pharmacotherapy, geriatrics / dementia care, pediatrics / neonatology, and interprofessional education. She has published about dermatology topics in book chapters in core pharmacotherapy textbooks used throughout the United States and Canada since 1997, spanning twelve editions in some textbooks. She has over 150 publications with the majority in the areas of dermatology and pharmacotherapy. She is a knowledgeable clinician with clinical practice experience for in-patient dermatology, geriatrics and dementia settings, internal medicine, hematology / oncology, palliative care, respiratory, and pediatrics / neonatology settings. Her fields of research included dermatology (dermatotoxicology, quantitative structure-activity relationships [QSARs], general dermatology), geriatrics, pediatrics, and education (pedagogy).

The Association of Faculties of Pharmacy of Canada (AFPC) has recognized her twice for her service to pharmacy academia: in 2012 with the AFPC Woods-Hughes Special Service Award In recognition of distinguished service to AFPC Council and Executive and in 2017 with a Special Recognition Award For 20 years of faithful volunteer service as Editor of the AFPC Newsletter.

She was recognized by Memorial University's Faculty of Medicine, Discipline of Family Medicine in 2016 with the George Hurley Award in Interprofessional Education For excellence of nonphysician teaching contributions to the Residency Training Program,

As a group award where she was an author, in 2008, the American Medical Writers Association (AMWA) awarded the textbook Pharmacotherapy Principles & Practice, 1st edition with the AMWA Distinguished 2008 Medical Book Healthcare Professionals Award as the best new textbook of 2008.

She has been a journal reviewer for many journals including the Journal of Pediatric Pharmacology and Therapeutics (JPPT), Journal of Toxicology and Environmental Health, Annals of Dermatological Research, Pharmacotherapy. Pediatric Research, Case Reports in Perinatal Medicine, BMC Health Services Research, and Pharmacy Practice.

Dr. Howard Maibach sees patients at The Environmental Dermatoses Clinic, which is part of the Dermatology Clinic at UCSF. His most active fields of research are in dermatopathology, dermatotoxicology and environmental dermatoses. He has been doing human subject research for over fifty (50) years. Dr. Maibach has been on the editorial board of more than 30 scientific journals. His bibliography includes 3,075+ manuscripts and over 150 books.

Inhalt

Section 1. General Principles.- Chapter 1.20 Clinically Pertinent Factors/Observations for Percutaneous Absorption in Humans.- Chapter 2.Pharmaceutical Compounding of Topical Dermatologic Treatments.- Chapter 3. Pharmacogenomics.- Chapter 4.Clinical pharmacology of dermatology products in pediatric drug development.- Chapter 5.Clinical Pharmacology of Topical Therapy in Pediatrics.- Chapter 6.Topical drug use in the elderly.-Chapter 7.Systemic considerations relating to topical drug treatment.-Section 2. Drug Monographs.-Chapter 8. Acne and Topical Drug Traeatments.- Chapter 9. Rosacea and Topical Drug Treatments.- Chapter 10.Topical drug treatment in actinic keratosis.- Chapter 11.Topical analgesics.- Chapter 12.Topical Antibiotics.- Chapter.13.Topical Antifungals.- Chapter 14.Topical Antineoplastics in Dermatology.- Chapter 15. Anti-pruritic Agents.- Chapter 16. Antiviral Agents.- Chapter 17. Atopic DermatitisTopical therapy.- Chapter 18. Topical Corticosteroids.- Chapter 19. Ectoparasiticides.- Chapter 20. Depigmenting and Pigmenting Agents.- Chapter 21. Psoriasis.- Chapter 22. Retinoids.- Chapter 23. Seborrheic Dermatitis.- Chapter 24. Sinecatechins. - Chapter 25. Sirolimus.- Chapter 26. Trichogenic and Antitrichogenic agents.- Chapter 27. Miscellaneous Agents.